Throughout 2022, Real World Health Care is covering the issue of racial and ethnic health disparities. This week, we explore the topic through the lens of gout, a type of arthritis that has a higher prevalence among racial and ethnic minorities, especially Blacks, than whites. Michael Spigler, vice president of…more.
- RWHC Home
- About RWHC
- Alzheimer’s Disease
- Amyotrophic Lateral Sclerosis
- Behavioral Health
- Movement Disorders
- Big Data
- Multiple Myeloma
- CAR-T Cell Therapy
- Non-Small Cell Lung Cancer
- Nonalcoholic Steatohepatitis
- COVID 19
- Pain Management
- Cystic Fibrosis
- Parkinson’s Disease
- Health Disparities
- Personalized Medicine
- Hepatitis C
- Secondary Progressive MS
- Macular Degeneration
Studies have shown that cancer disproportionately impacts racial and ethnic minority groups, however, these groups remain underrepresented in cancer clinical trials.1,2,3 With unique insights into issues facing underrepresented patient populations, the Association of Community Cancer Centers (ACCC) recently developed consensus-driven recommendations to improve diversity, equity and accessibility in cancer research.…more.
Social determinants of health (SDOH) have long-term, far-reaching, and not always obvious ramifications in people’s lives, including their risk for Alzheimer’s disease and related dementias (ADRD). These disparities were made clear by a 2020 report issued by UsAgainstAlzheimer’s and the Urban Institute. The report found that deep social inequities –…more.
First identified in 1989, the hepatitis C virus (HCV) kills thousands of people in the United States each year. An estimated 2.4 million Americans live with chronic hepatitis C infection, which if left untreated can result in serious, even life-threatening health problems like cirrhosis and liver cancer. While HCV knows…more.
More than 9.2 million Americans live with gout, but only 10 percent of people with gout are getting the ongoing treatment they need. The lack of proper treatment is particularly acute among Black patients, who have a 25 percent higher prevalence of the disease but are much less likely to…more.
Editor’s Note: The following has been excerpted, with permission, from The Parkinson’s Journey: Building a Care Team, published by The Michael J. Fox Foundation for Parkinson’s Research (MJFF). Real World Health Care invites our readers to visit MichaelJFox.org to help you and your loved ones navigate life with Parkinson’s. As…more.
The majority of people who get Parkinson’s Disease (PD) are over the age of 60. However, 10 to 20 percent of the 60,000 people diagnosed every year in the United States are under age 50 and about half of those are diagnosed before age 40. Because PD is typically associated…more.
Editor’s Note: The following information about Parkinson’s Disease was originally published by the National Institutes of Health‘s (NIH) National Institute on Aging (NIA), which leads a broad scientific effort to understand the nature of aging and to extend the healthy, active years of life. You can read the original information…more.
Precision medicine – treatments that are based on an individual’s specific genetics and the cancer cell’s genes – holds great promise for lung cancer patients. For all patients, precision medicine is made possible through a type of advanced diagnostic testing called biomarker testing. However, for some racial and ethnic minorities,…more.
Alzheimer’s disease is a leading cause of death in the United States and millions of Americans are affected by the disease. It’s important to distinguish the facts from the myths about Alzheimer’s, especially when it comes to finding information online. The following information about common myths surrounding Alzheimer’s was originally…more.